×
google news

Why we should be worried about drug-resistant fungal infections

C. auris is not just a buzzword; it's a serious health threat. Here’s what you need to know.

Health officials across Europe are sounding the alarm about a serious health threat: the fungal infection Candida auris, commonly known as C. auris. This issue has escalated rapidly, with over 4,000 infections reported between 2013 and 2023, including a 67% increase in cases over the past year alone.

In 2023, there were 1,346 new cases. The World Health Organization (WHO) has classified C. auris as a significant threat to public health.

What is C. auris and why should we care?

C. auris is a fungal infection that has raised concerns among health professionals.

The infection is particularly dangerous, with nearly 60% of those infected dying within 90 days. The European Centre for Disease Prevention and Control (ECDC) has noted a concerning rise in case numbers and outbreaks across Europe, indicating a pressing need for increased awareness and action.

How is C. auris spreading?

C. auris primarily spreads in healthcare facilities, particularly affecting critically ill patients. It can cause severe infections in various body parts, including the bloodstream, brain, and respiratory system. Moreover, C. auris can survive on hospital surfaces and even human skin for extended periods, complicating efforts to eliminate it.

Recent investigations in British hospitals revealed traces of C. auris on various surfaces, including medical equipment and sinks. In the last decade, 18 countries have reported cases, with Spain, Greece, and Italy seeing the highest numbers. New outbreaks have also emerged in Cyprus and France, highlighting the fungus’s rapid spread.

The implications of rising resistance

Resistance to antifungal medications poses a significant challenge in treating C. auris infections. Only four new antifungal drugs have been approved in the past decade, raising concerns about treatment options. The overuse of antifungals, particularly where they are available over-the-counter, could exacerbate this issue.

Dr. Diamantis Plachouras from the ECDC emphasizes that insufficient surveillance and delayed diagnosis are allowing C. auris to infiltrate hospitals unnoticed. Additionally, rising temperatures may create an environment conducive to fungal growth, potentially leading to a public health crisis.

Addressing this issue requires a concerted effort to enhance early detection and implement stringent infection control measures. The responsibility extends beyond healthcare facilities; community involvement is essential in curbing the spread of C. auris.


Contacts:

More To Read